Correlation of the handheld Health Management Tool (HMT) home self testing on the days of site visits and the mVT assessments performed during the site visits for absolute values [ Time Frame: after 16 weeks ] [ Designated as safety issue: No ]

Correlation between the home deterioration signal and the monthly change in the handheld Health Management Tool (HMT) assessments performed during the site visits [ Time Frame: after 16 weeks ] [ Designated as safety issue: No ]

Patient compliance and reliability of performing the home self testing using the handheld Health Management Tool (HMT) [ Time Frame: after 16 weeks ] [ Designated as safety issue: No ]

A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab

Brief Summary

This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.

Detailed Description

Not Provided

Study Type ICMJE

Interventional

Study Phase

Phase 4

Study Design ICMJE

Intervention Model: Single Group AssignmentMasking: Open Label

Condition ICMJE

Age Related Macular Degeneration (AMD)

Intervention ICMJE

Device: Health Management Tool (HMT)

utilization of software specific for measuring vision impairment on a mobile computing platform (ie HMT) which allows subjects to perform home monitoring tests

Study Arm (s)

other application for monitoring

Intervention: Device: Health Management Tool (HMT)

Publications *

Not Provided

* Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.